Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami ShahDesignation :- Company Secretary and Compliance Officer Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Submission of documents post approval of Scheme by the National Company Law Tribunal (NCLT), Mumbai Bench Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith are the details regarding the voting results of the business transacted at the 34th AGM of the Company held on Friday, 28th September, 2018 at VITS- Luxury Business Hotel, Andheri Kurla Road, International Airport Zone, Andheri (E), Mumbai 400059 in the prescribed format.... Announcement under Regulation 30 (LODR)-Scheme of Arrangement
With reference to captioned subject, the Company had informed you vide its letter dated September 20, 2018 that the Board of Directors of the Company at its Meeting held on September 20, 2018, inter alia has approved the Scheme of Amalgamation of Gufic Lifesciences Private Limited with the Company and their respective shareholders and creditors, subject to the approval of the shareholders and regulatory authorities.... Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to the provisions of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the proceedings of the 34th Annual General Meeting (AGM) of the Company held on Friday, 28th September, 2018 at 2.30 p.m. at VITS - Luxury Business Hotels, Andheri Kurla Road, International Airport Zone, Andheri (East), Mumbai - 400 059. Announcement under Regulation 30 (LODR)-Scheme of Arrangement
With reference to captioned subject, we would like to inform you that the Board of Directors of the Company at its Meeting held today i.e. September 20, 2018, inter alia has approved the Scheme of Amalgamation of Gufic Lifesciences Private Limited with the Company and their respective shareholders and creditors. The details as required under SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with SEBI Circular... Announcement under Regulation 30 (LODR)-Scheme of Arrangement
In furtherance to the letter dated September 06, 2018 to the Exchanges pertaining to the pronouncement of National Company Law Tribunal, Mumbai bench (NCLT) order sanctioning the Scheme of Merger by Absorption of Gufic Stridden Bio-Pharma Private Limited ('Transferor Company') with Gufic Biosciences Limited ('Transferee Company') and their respective shareholders at its hearing held on September 06, 2018, enclosed is the certified true copy of the order.... Newspaper Cutting Of Published Notice Of The 34Th AGM, Book Closure And E-Voting
Enclosed herewith the cutting of newspaper in which notice of the 34th AGM, Book Closure and E-voting of the Company confirming the completion of dispatch to eligible shareholders were published. The said information were published in Business Standard (English Edition) and Mumbai Lakshadeep (Marathi Edition) dated September 07, 2018. Fixes Book Closure for Dividend & AGM (Cut-off date for e-voting)
Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2018 to September 28, 2018 (both days inclusive) for the purpose of Payment of Dividend & 34th Annual General Meeting (AGM) of the Company to be held on September 28, 2018.